Expertise in
39
conditions

Dr. Mark G. Lebwohl

Internal Medicine
Icahn School Of Medicine At Mount Sinai
5 E 98th St, 
New York, NY 
Accepting New Patients
Before you request
Expertise in
39
conditions
Icahn School Of Medicine At Mount Sinai
5 E 98th St, 
New York, NY 

Overview

Mark Lebwohl is a primary care provider, practicing in Internal Medicine in New York, New York.

Dr. Lebwohl is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Psoriasis, Pustular Psoriasis, and Generalized Pustular Psoriasis (GPP).

He is actively involved in clinical research, co-authoring 520 peer reviewed articles and participating in 6 clinical trials. Dr. Lebwohl is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Dermatology in NY

Hospital Affiliations

Mount Sinai Beth Israel
Mount Sinai Hospital
Mount Sinai West

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Card System
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
MVP Health
  • EPO
  • PPO
Nippon Life
  • INSURANCE PLAN
Northwell Health
  • INSURANCE PLAN
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Icahn School of Medicine at Mount Sinai
5 E 98th St, New York, NY 10029

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata
An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata
Enrollment Status: Terminated
Publish Date: March 11, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies
A Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies
Enrollment Status: Completed
Publish Date: March 10, 2021
Intervention Type: Drug
Study Phase: Phase 4
A Split Body Study of the Effects of Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
A Split Body Study of the Effects of Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
Enrollment Status: Completed
Publish Date: August 28, 2019
Intervention Type: Procedure, Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

519 Total Publications

Topical Sirolimus for Refractory Cutis Marmorata Telangiectatica Congenita in Adulthood: A Case Report.
Topical Sirolimus for Refractory Cutis Marmorata Telangiectatica Congenita in Adulthood: A Case Report.
Journal: Journal of drugs in dermatology : JDD
Published: September 04, 2026
Similar Doctors
Expertise in
13
conditions
Dr. Ryan C. Ungaro
Internal Medicine
Expertise in
13
conditions
Dr. Ryan C. Ungaro
Internal Medicine

MSSM-Optical Shop

17 E 102nd St, 
New York, NY 
 (0.2 miles away)
212-241-8100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ryan Ungaro is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Ungaro is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Ulcerative Colitis, Colonoscopy, and Endoscopy.

Expertise in
14
conditions
Dr. John P. Bilezikian
Internal Medicine
Expertise in
14
conditions
Dr. John P. Bilezikian
Internal Medicine
Before you request

NewYork Presbyterian Columbia University Irving Medical Center

180 Fort Washington Ave, 
New York, NY 
 (3.6 miles away)
212-305-2663
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Bilezikian is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Bilezikian is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Hypoparathyroidism, Hypercalcemia, Milk-Alkali Syndrome, Parathyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Bilezikian is currently accepting new patients.

Expertise in
26
conditions
Expertise in
26
conditions

Mount Sinai

1 Gustave L Levy Pl, 
New York, NY 
 (0.2 miles away)
212-241-0764
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Charlotte Cunningham-Rundles is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Cunningham-Rundles is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Common Variable Immune Deficiency, Primary Immunodeficiency (PID), X-Linked Agammaglobulinemia, and Immunodeficiency with Hyper IgM Type 1.

Frequently Asked Questions about Dr. Mark G. Lebwohl

How do I make an appointment with Dr. Mark G. Lebwohl?

You can book an appointment with Dr. Mark G. Lebwohl by calling their office at 212-241-9728. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark G. Lebwohl a top-rated expert for Plaque Psoriasis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark G. Lebwohl is classified as an Elite expert for Plaque Psoriasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark G. Lebwohl specialize in?

While Dr. Mark G. Lebwohl is a Internal Medicine, they have specific expertise in Plaque Psoriasis, Psoriasis, and Pustular Psoriasis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Mark G. Lebwohl participate in research or clinical trials?

Yes. Dr. Mark G. Lebwohl has published 519 articles and abstracts on conditions like Plaque Psoriasis. You can view a list of Dr. Mark G. Lebwohl's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark G. Lebwohl accept my insurance?

Dr. Mark G. Lebwohl accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-241-9728 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lebwohl's expertise for a condition
ConditionClose
View All 10 Elite Conditions
View All 8 Distinguished Conditions
View All 21 Advanced Conditions
View All 67 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile